Register for streaming realtime charts, analysis tools, and prices.

Get Started

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

Date	Time	Source	Headline	Symbol	Company
05/05/2023	5:16PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
05/05/2023	4:50PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:IMGN	ImmunoGen Inc
05/05/2023	4:28PM	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:IMGN	ImmunoGen Inc
05/04/2023	7:45PM	Business Wire	ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock	NASDAQ:IMGN	ImmunoGen Inc
05/03/2023	4:07PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:IMGN	ImmunoGen Inc
05/03/2023	4:01PM	Business Wire	ImmunoGen Announces Proposed Public Offering of Common Stock	NASDAQ:IMGN	ImmunoGen Inc
05/03/2023	9:01AM	Dow Jones News	ImmunoGen Shares Rise 96% on Positive Data From Elahere Trial	NASDAQ:IMGN	ImmunoGen Inc
05/03/2023	6:36AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
05/03/2023	6:30AM	Business Wire	ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer	NASDAQ:IMGN	ImmunoGen Inc
05/02/2023	5:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
05/02/2023	4:32PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
05/01/2023	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
04/28/2023	6:42AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
04/28/2023	6:30AM	Business Wire	ImmunoGen Reports Recent Progress and First Quarter 2023 Financial Results	NASDAQ:IMGN	ImmunoGen Inc
04/26/2023	5:16PM	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:IMGN	ImmunoGen Inc
04/26/2023	5:02PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:IMGN	ImmunoGen Inc
04/24/2023	6:30AM	Business Wire	ImmunoGen Appoints Isabel Kalofonos as Senior Vice President and Chief Commercial Officer	NASDAQ:IMGN	ImmunoGen Inc
04/13/2023	4:01PM	Business Wire	ImmunoGen Announces Conference Call to Discuss Its First Quarter 2023 Operating Results	NASDAQ:IMGN	ImmunoGen Inc
04/06/2023	6:30AM	Business Wire	ImmunoGen Announces Non-Dilutive Term Loan Financing for Up to $175 Million with Pharmakon Advisors	NASDAQ:IMGN	ImmunoGen Inc
04/04/2023	4:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
04/04/2023	4:52PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
04/03/2023	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
03/25/2023	9:00AM	Business Wire	ImmunoGen Presents Final Overall Survival and Additional Efficacy Data from the SORAYA Trial at SGO Annual Meeting	NASDAQ:IMGN	ImmunoGen Inc
03/01/2023	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
03/01/2023	6:53AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
03/01/2023	6:43AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
03/01/2023	6:30AM	Business Wire	ImmunoGen Reports Recent Progress and 2022 Financial Results	NASDAQ:IMGN	ImmunoGen Inc
03/01/2023	6:25AM	Business Wire	ImmunoGen Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of ImmunoGen's ADC Technology in the Development of Novel Targeted Conditioning Agents	NASDAQ:IMGN	ImmunoGen Inc
02/22/2023	4:30PM	Business Wire	ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences	NASDAQ:IMGN	ImmunoGen Inc
02/15/2023	4:01PM	Business Wire	ImmunoGen Announces Conference Call to Discuss Its 2022 Operating Results	NASDAQ:IMGN	ImmunoGen Inc

Showing the most relevant articles for your search:NASDAQ:IMGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

Ethema Health (PK)

Northwest Biotherapeutics (QB)

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

1812 Brewing (PK)

Faraday Future Intellige...

Digital Brand Media and ... (PK)

SMC Entertainment (PK)

Fannie Mae (QB)

Anavex Life Sciences

Emergent Health (PK)

Bioelectronics (PK)

Branded Legacy (PK)

Delayed Upgrade Clock